# Treatment of Acute Hepatitis C Virus in HIV Co-Infection

> **NCT00845676** · PHASE4 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 21 (actual)

## Conditions studied

- Hepatitis C
- Human Immunodeficiency Virus
- HIV Infections

## Interventions

- **DRUG:** Pegylated interferon alfa-2a + Ribavirin

## Key facts

- **NCT ID:** NCT00845676
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2010-12
- **Final completion:** 2013-12
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2020-05-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00845676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00845676, "Treatment of Acute Hepatitis C Virus in HIV Co-Infection". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00845676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*